National Institutes of Health Reproductive and Adult Endocrinology
Search  
Miscellaneous 
 

 

The Office of Research on Women's Health would like to make you aware of the Upcoming 3rd NIH International Fibroid Congress.
For Information, Registration, and Abstract Submission (Deadline: October 15, 2010) visit: http://tools.niehs.nih.gov/conferences/fgc/

SAVE THE DATE
NOVEMBER 22-23, 2010
William H. Natcher Conference Center
National Institutes of Health
Bethesda, MD 20892

Sponsored by:
DEPARTMENT OF HEALTH AND HUMAN SERVICES

NATIONAL INSTITUTES OF HEALTH
Office of Research on Women’s Health (ORWH)
National Institute of Environmental Health Sciences (NIEHS)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Cancer Institute (NCI)
National Center for Research Resources (NCRR)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Institute of Nursing Research (NINR)
 
and
 
OFFICE OF WOMEN’S HEALTH/OFFICE OF THE SECRETARY (OWH/OS)
AGENCY FOR HEALTHCARE RESEARCH AND QUALITY (AHRQ)
CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC)
FOOD AND DRUG ADMINISTRATION (FDA)
HEALTH RESOURCES & SERVICES ADMINISTRATION (HRSA)


Conference Objectives

Uterine leiomyomas (fibroids) are the most common gynecologic neoplasms in women of reproductive age. As the number one cause of hysterectomy, they have a profoundly negative impact on women’s health. Uterine leiomyomas are hormonally dependent and as such are a potential target for endocrine active compounds in the environment.

The goal of this conference is to bring together researchers working in the fields of medicine, epidemiology, basic research, and therapeutics to foster an exchange of scientific information among members of the uterine leiomyoma research community. Participants will be drawn from academia, medicine, government, and industry.

Topics to be covered include Clinical Management and Therapeutic Strategies, Epidemiology, Pathogenesis, Environmental Influences, Model Systems, Hormonal Regulation, and Molecular and (Epi)Genetic Characteristics.

Glenda Moser, PhD, DABT
Program Manager Toxicology and Cancer Biology
601 Keystone Dr. Suite 100
Durham, NC 27713
919-281-1110 ext 723
gmoser@ils-inc.com

 
National Institutes of Health (NIH), 9000 Rockville Pike, Bethesda, Maryland 20892.
  Department of Health and Human Services   USA.gov - Government made easy